Motivadores de aquisições na indústria farmacêutica brasileira: portfólio em risco e inovação
Carregando...
Arquivos
Data
2016-10-21
Autores
Orientador(res)
Saito, Richard
Métricas
Título da Revista
ISSN da Revista
Título de Volume
Resumo
According to the literature, portfolio of products at risk due to the loss of exclusivity and the search for innovation are mentioned as drivers of acquisitions in the pharmaceutical industry. Considering data of 530 companies and 56 acquisitions in the Brazilian pharmaceutical market from 2005 to 2015, we analyzed how buyers evaluate their targets according to their products profile, innovation scores and indicators of assets at risk due to the loss of technological exclusivity. In contrast to the current literature in developed markets, we found empirical evidences that the main driver of buyers in Brazil is the excess of capacity due to technological shocks, but there is no active search for new technologies. This scenario shows that asset transactions are translated into a continuous substitution of innovations by copies in the structure of the companies.